Cargando…
Interaction between warfarin and molnupiravir in a patient with coronavirus disease 2019 infection
Molnupiravir is a novel antiviral agent for coronavirus disease 2019 (COVID-19) treatment. Warfarin is an oral anticoagulation agent with difficult management due to drug interactions. Here, we describe a case of international normalized ratio (INR) prolongation in a patient who administrated warfar...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041292/ https://www.ncbi.nlm.nih.gov/pubmed/36993011 http://dx.doi.org/10.4103/jfmpc.jfmpc_1387_22 |